Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 16 Beta-ethyl-17 Beta-hydroxyestr-4-en-3-one
2. 16 Beta-ethyl-19-nortestosterone
3. 16 Ethyl-17-hydroxy-4-estren-3-one
4. Ehoo
5. Tsaa 291
6. Tsaa-291
7. Tsaa291
1. 33765-68-3
2. Prostetin
3. Tsaa-291
4. Mn4i850d4p
5. Ncgc00183854-01
6. (8r,9s,10r,13s,14s,16s,17s)-16-ethyl-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one
7. Oxendolona
8. Oxendolonum
9. (8r,9s,10r,13s,14s,16s,17s)-16-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3h-cyclopenta[a]phenanthren-3-one
10. Oxendolonum [inn-latin]
11. Oxendolona [inn-spanish]
12. Unii-mn4i850d4p
13. Oxendolone [usan:inn:jan]
14. 16-beta-ethyl-19-nortestosterone
15. Prostetin (tn)
16. 16-ethyl-17-hydroxyester-4-en-3-one
17. Oxendolone [mi]
18. Oxendolone [inn]
19. Oxendolone [jan]
20. Oxendolone [usan]
21. 16beta-ethyl-17beta-hydroxyestr-4-en-3-one
22. Oxendolone [mart.]
23. 16-beta-ethyl-17-beta-hydroxyestr-4-en-3-one
24. Dsstox_cid_28740
25. Dsstox_rid_83009
26. Oxendolone [who-dd]
27. Dsstox_gsid_48814
28. Oxendolone (jan/usan/inn)
29. Schembl233297
30. Chembl513856
31. Dtxsid8048814
32. Chebi:31946
33. Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16-beta,17-beta)-
34. Zinc4217221
35. Tox21_113291
36. Akos016014084
37. Cas-33765-68-3
38. 16beta-ethyl-17beta-hydroxy-4-estren-3-one
39. 17beta-hydroxy-16beta-ethyl-4-estren-3-one
40. D01329
41. Q15633970
42. (16beta,17beta)-16-ethyl-17-hydroxyestr-4-en-3-one
43. Estr-4-en-3-one, 16-beta-ethyl-17-beta-hydroxy-
44. 16.beta.-ethyl-17.beta.-hydroxyestr-4-en-3-one
45. Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16beta,17beta)-
46. Allyl-2,3-di-o-benzyl-4,6-o-benzylidene-alpha-d-glucopyranoside
47. Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16.beta.,17.beta.)-
Molecular Weight | 302.5 g/mol |
---|---|
Molecular Formula | C20H30O2 |
XLogP3 | 3.4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 302.224580195 g/mol |
Monoisotopic Mass | 302.224580195 g/mol |
Topological Polar Surface Area | 37.3 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 508 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Oxendolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxendolone, including repackagers and relabelers. The FDA regulates Oxendolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxendolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oxendolone supplier is an individual or a company that provides Oxendolone active pharmaceutical ingredient (API) or Oxendolone finished formulations upon request. The Oxendolone suppliers may include Oxendolone API manufacturers, exporters, distributors and traders.
click here to find a list of Oxendolone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxendolone DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxendolone active pharmaceutical ingredient (API) in detail. Different forms of Oxendolone DMFs exist exist since differing nations have different regulations, such as Oxendolone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxendolone DMF submitted to regulatory agencies in the US is known as a USDMF. Oxendolone USDMF includes data on Oxendolone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxendolone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxendolone suppliers with USDMF on PharmaCompass.
Oxendolone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxendolone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxendolone GMP manufacturer or Oxendolone GMP API supplier for your needs.
A Oxendolone CoA (Certificate of Analysis) is a formal document that attests to Oxendolone's compliance with Oxendolone specifications and serves as a tool for batch-level quality control.
Oxendolone CoA mostly includes findings from lab analyses of a specific batch. For each Oxendolone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxendolone may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxendolone EP), Oxendolone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxendolone USP).
LOOKING FOR A SUPPLIER?